Activist 13D/13G Filings - Lilly Ventures Fund I LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2021-02-12
5:16 pm
Purchase
13GFORMA THERAPEUTICS HLDGS INC
FMTX
Lilly Ventures Fund I LLC2,404,069
5.2%
2,404,069increase
(New Position)
View
2021-02-12
5:08 pm
Sale
13GSURFACE ONCOLOGY INC
SURF
Lilly Ventures Fund I LLC3,447,817
8.5%
-36,801decrease
(-1.06%)
View
2021-02-12
4:59 pm
Sale
13GAEGLEA BIOTHERAPEUTICS, INC. C
AGLE
Lilly Ventures Fund I LLC2,568,543
5.4%
-80,666decrease
(-3.04%)
View
2020-06-08
4:04 pm
Sale
13DPROTAGONIST THERAPEUTICS INC C
PTGX
Lilly Ventures Fund I LLC1,559,060
4.5%
-540,422decrease
(-25.74%)
View
2020-02-13
4:17 pm
Sale
13GSUTRO BIOPHARMA INC
STRO
Lilly Ventures Fund I LLC968,161
4.2%
-572,652decrease
(-37.17%)
View
2020-02-13
4:17 pm
Purchase
13GAEGLEA BIOTHERAPEUTICS, INC. C
AGLE
Lilly Ventures Fund I LLC2,649,209
9.1%
16,400increase
(+0.62%)
View
2020-02-13
4:17 pm
Purchase
13GSURFACE ONCOLOGY INC
SURF
Lilly Ventures Fund I LLC3,484,618
12.5%
30,741increase
(+0.89%)
View
2019-08-13
5:00 pm
Unchanged
13DAILERON THERAPEUTICS INC
ALRN
Lilly Ventures Fund I LLC1,094,987
3.9%
0
(Unchanged)
View